The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
05/02/2012
. If
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
opportunity click
send
me change notification emails
.
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
printed document.
Document Type:
Grants Notice
Funding Opportunity Number:
W81XWH-12-ARP-IDA
Opportunity Category:
Discretionary
Posted Date:
May 02, 2012
Creation Date:
May 02, 2012
Original Closing Date for Applications:
Sep 20, 2012
Current Closing Date for Applications:
Sep 20, 2012
Archive Date:
Oct 20, 2012
Funding Instrument Type:
Cooperative Agreement
Grant
Category of Funding Activity:
Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:
5
Estimated Total Program Funding:
$3,200,000
Award Ceiling:
Award Floor:
CFDA Number(s):
12.420
--
Military Medical Research and Development
Cost Sharing or Matching Requirement:
No
Eligible Applicants
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility:
Agency Name
Dept. of the Army -- USAMRAA
Description
The ARP Idea Development Award supports the development of innovative, high-impact ideas that advance the understanding of ASD and that ultimately will lead to improved outcomes for individuals with autism. Through the Idea Development Award, the ARP seeks to promote multidisciplinary collaborations (e.g., special education, biomedical science, preclinical research); to develop and validate biologically relevant animal models of autism (with appropriate justification for its relevance to a given subgroup); to investigate the implications of immunological response and ASD; and to leverage existing biological samples, clinical populations, and databases to provide power to test ideas.
Link to Additional Information
If you have difficulty accessing the full announcement
electronically, please contact:
